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Background: Ocular melanosis of Cairn terrier dogs is an inherited defect characterized by progressive
pigmentation of both eyes which can result in glaucoma and blindness. Pedigree analysis suggests the trait has an
autosomal dominant mode of inheritance. We selected 11 potential candidate genes and used an exclusion
analysis approach to investigate the likelihood that one of the candidate gene loci contained the Cairn
terrier-ocular melanosis locus.
Results: Two polymorphic loci were identified within or close to each candidate gene. Genotyping of at least 10
ocular melanosis Cairn terriers for each marker showed that there was no single shared allele for either of the
two polymorphic markers identified in ASIP, COMT, GPNMB, GSK3B, LYST, MC1R, MITF, SILV, TYR, TYRP1,and TYRP2.
This is strong evidence to exclude each locus as the site of the ocular melanosis mutation (probability of a false
exclusion calculated for each gene ranged from 1.59 × 10-4 to 1 × 10-9).
Conclusions: None of the 11 potential candidate genes selected are likely to be the gene locus for ocular
melanosis in Cairn terriers.
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Ocular melanosis (OM) is a hereditary condition in the
Cairn terrier breed of dog that is characterized by prolif-
eration and migration of pigmented cells starting in the
anterior uvea of both eyes. The pigmented cells result in
a diffuse expansion of the root of the iris and are also
shed into the aqueous humor. They accumulate in the
anterior sclera which develops pigment plaques that pro-
gressively increase in size, possibly reaching that site via
the conventional aqueous drainage pathways [1,2]. Even-
tually the aqueous drainage pathways become blocked
with pigment results in secondary glaucoma and vision
loss. The pigmented cells appear to be primarily melano-
cytes although some admixture with melanophages
(macrophages that have ingested melanosomes) does
occur [3]. The pigmented cells also reach the posterior
segment of the eye and over time can be seen to slowly
migrate into and obscure the tapetum [2]. The posterior* Correspondence: peter315@cvm.msu.edu
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reproduction in any medium, provided the orsclera also becomes pigmented and pigment can be
found in the meninges around the optic nerve. Trans-
formation to develop solid melanocytic tumors occurs in
some cases and was reported in 3 dogs in a series of 114
ocular melanosis affected Cairn terriers [3].
Cairn terrier OM shares some similarities with human
pigment dispersion syndrome (PDS). PDS patients accu-
mulate pigment within the trabecular meshwork, and a
subset (approximately 35% by 35 years following PDS
diagnosis) develop pigmentary glaucoma (PG) [4]. This
condition accounts for 1–1.5% of human glaucoma cases
seen in the Western world [5]. Although the PDS causa-
tive mutation/s has yet to be identified, the phenotype
has been linked to the telomere region (7q35-q36) of
human chromosome 7 [6].
Rodent models with pigment changes similar to human
PDS and PG, and pseudoexfoliation have been described.
In the DBA/2 J mouse, mutations in GPNMB and TYRP1
result in iris pigment dispersion and iris stromal atrophy
respectively and mice homozygous for recessive alleles
at both loci have earlier onset and more severe disease
[7,8]. Clinically this mouse model closely resembles
Cairn terrier OM. More recently a mutation in LYSTLtd. This is an Open Access article distributed under the terms of the Creative
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in mice [9].
OM in Cairn terriers represents a potentially im-
portant large animal model for investigation of human
PDS and PG. Pedigree analysis indicates that Cairn
terrier OM is likely to be inherited as an autosomal
dominant trait [2]. We tested the hypothesis that one
of 11 candidate genes has suffered a mutation that
causes OM phenotype by examination of allele sharing
of genetic markers close to or within each gene. Using
an association-based form of exclusion analysis (as op-
posed to pedigree-based exclusion analysis), we pro-
vide evidence that strongly supports the exclusion of
these 11 candidate genes from association with OM in
the Cairn terrier.Table 1 Candidate genes for Cairn terrier ocular melanosis w
Gene, Protein, Positiona Markerb [Restriction enzym
LYST Lysosomal Trafficking Regulator
chr4:7,128,220-7,294,031
Microsat 1 (TTTTC)18(TTTTC)11
Microsat 2 (GAAA)5 (GAAA)13
MC1R Melanocortin 1 receptor
chr5:66,692,398-66,693,344
SNP 1 (BICF2P987741)





TYRP1 Tyrosinase related protein 1
chr11:36,344,712-36,361,793




SNP 1 (BICF2P753624) [HpyCH
SNP 2 (BICF2P134952)
MITF Microphthalmia transcription factor
chr20:24,853,657-24,884,775






TYRP2 (DCT) Tyrosinase related protein 2
chr22:48,219,817-48,254,000
SNP 1 (BICF2S23137809) [sequ
SNP 2 (BICF2P452919) [RsaI]
ASIP Agouti signaling protein
chr24:26,327,360-26,366,307




SNP 1 (BICF2S22923369) [Apa
Microsat 1 (TTTA)15





a. Genes are listed in chromosomal order as obtained from the May 2005 build of th
with the encoded proteins provided under the gene names.
b. Microsatellite-based markers are shown with the repeat type and number of perf
separated by one to several nucleotides that do not match the perfect repeat. SNPs
broadinstitute.org/mammals/dog). One marker for ASIP is an in/del of an undefined
method of genotyping SNPs is shown in square brackets. Note some were genotyp
c. The location of each marker is given with respect to coding region of each gene
Designations are upstream (1) or downstream (2) of the gene start site, or within th
midpoint (M2).
d. Distances are given from each marker to furthest end of the gene from that mar
e. Each P value is the probability (combined probability of the two markers) of false
Methods for an example of how this was calculated). The method used for each ma
mutation rate, Δ used rate of recombination between marker and coding region, o
(probability of the recombination WITHIN the gene), * Clark’s method for haplotypeResults
Candidate genes
Eleven potential candidate genes for ocular melanosis
were selected: agouti signaling protein (ASIP), catechol-o-
methyltransferase (COMT), glycoprotein NMB (GPNMB),
glycogen synthase kinase 3-beta (GSK3B), lysosomal traf-
ficking regulator (LYST), melanocortin 1 receptor (MCIR),
microphthalmia transcription factor (MITF), silver (SILV),
tyrosinase (TYR), tyrosinase related protein 1 (TYRP1), and
Tyrosinase related protein 2 (TYRP2). For each gene two
polymorphic markers were identified (11 single nucleotide
polymorphisms (SNPs), 9 microsatellites (MS), 2 insertion/
deletions (in/dels)) that could be used to test for associ-
ation of the candidate locus with Cairn terrier OM. Details
of the candidate genes and markers are shown in Table 1.ith markers, chromosomal positions, and PCR primers
e] Marker Positionc Distance (kb)d P valuese
1§ 345 1.00 × 10-5
2§ 368
2Δ 560 1.34 × 10-5
1Δ 24
2§ 60 1.00 × 10-5
1§ 226
] 1Δ 224 2.15 × 10-5
2Δ 96
4V] M1° 26 1.59 × 10-4
2Δ 1200
HI] 2Δ 73 3.80 × 10-5
1Δ 521
(GAAA)10 2§ 428 1.00 × 10-9
TC)13 1§ 70
enced] M2° 33 8.47 × 10-4
M1° 8
1Δ 340 3.57 × 10-5
2Δ 105
LI] 2Δ 82 8.20 × 10-5
1§ 676
M2* 146 1.00 × 10-5
M2* 143
e canine reference genome (UCSC Genome Browser: http://genome.ucsc.edu/),
ect repeats present in the canine reference genome. Repeat blocks are
are listed with Broad Institute CanFam 2.0 SNP designation (http://www.
but variable nature. The restriction enzyme used for PCR-restriction enzyme
ed by sequencing.
as seen in the 2005 canine reference genome on UCSC Genome Browser.
e gene upstream of the exact midpoint (M1) or to the downstream of the
ker.
ly excluding the true causative gene (see Additional file 2: Supplementary
rker is indicated in the column showing marker position: § used microsatellite
used rate of recombination from marker to nearest end of the coding region
analysis [10].
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Exclusion analysis was performed under several assump-
tions that are considered to be robust for canine Mendelian
disorders; (1) all affected dogs share the same causal muta-
tion, which is identical by descent due to a founder event
(very likely, based upon previous results for common
Mendelian mutations in purebred dogs; see Discussion),
(2) no recombination has occurred between the marker
and the mutation since the time the unique mutational
event occurred (markers are very close to the gene and the
probability of a rare event is calculated and presented), and
(3) no new mutations have occurred in either the marker
or the gene (also included in the probability calculation for
a false exclusion). It is important to understand that, for the
purpose of exclusions, only affected dogs are needed. This
is analogous to exclusion in paternity testing. If an accused
male does not share marker alleles with the baby, he cannot
be the father; knowing or not knowing the marker allele
frequencies in the population has no impact on the exclu-
sion. It is only necessary to have allele frequency informa-
tion when the alleles in the offspring are consistent with
those of the accused male in order to provide a probability
statement on how likely this match is compared to other
possible males in the population. We sought to exclude
most candidate genes as quickly and affordably as possible
because only one gene can underlie a Mendelian disorder
due to a founder event and the rest of the candidate genes
are “innocent” with respect to the disease under exami-
nation. An advantage to this approach is the cost savings
obtained because it is not necessary to genotype unaffected
controls. Controls only need to be genotyped if a gene can-
not be excluded, in order to obtain positive evidence of an
association between a locus and the disease phenotype.
Note also that penetrance is not an issue because all Cairn
terriers genotyped are affected and must share the neces-
sary allele.
With a likely dominant mode of inheritance, markers
within or close to the gene harboring the causal mutation
(or a necessary locus) would have at least one shared allele
between affected dogs. For each of the 22 markers geno-
typed there was no shared single allele between the OM-
affected dogs thus providing evidence that none of the
candidate genes underlie OM (Additional file 1: Table S1
and Table S2). We then calculated the probability of falsely
excluding the candidate genes: the p values ranged from
1.59 × 10-4 to 1.0 × 10-9 (Table 1 and Additional file 2),
making it very unlikely that any one the 11 candidate
genes tested contains the OM mutation.
Discussion
Linkage-based and sequence-based exclusion analyses
have been used in many studies to eliminate candidate
genes hypothesized to underlie inherited phenotypes in
dogs (for example: [11-13]). With late-onset conditionssuch as ocular melanosis compiling pedigrees (DNA
and phenotypes from multiple offspring and at least one
parent) can be difficult because it may not be possible to
locate the siblings or the parents of affected animals, or
they may already be dead. Sequencing of candidate genes
can be time consuming and since the commonest ap-
proach is to sequence only the exons and flanking por-
tions of the introns, the method could miss causal
mutations in non-coding regions. In this study we used
association-based exclusion analysis, a technique that re-
quires only the use of animals affected with the condi-
tion and can be used for rapid exclusion of candidate
loci. Obviously the hope is to identify a candidate locus
that cannot be excluded and would thus warrant further
investigation as the potential site of the disease causing
mutation. Using association-based exclusion analysis we
were able to exclude with high probability 11 candidate
genes for OM in Cairn terriers.
We argue here that the assumptions (no locus or al-
lelic heterogeneity, or recombination and/or new muta-
tions, as listed in the Results section) that underlie this
approach are appropriate. Giger and colleagues noted
that, with very few exceptions, the causative mutations
that have been identified for canine genetic diseases are
breed specific or affect very closely related breeds [14].
The relative rarity of a Cairn terrier-ocular melanosis-
like condition in any other breed of dog makes it very
likely that this condition also resulted from a single
mutation event.
We have estimated the probability of a recombination
event causing a false exclusion of the true locus based
upon the average recombination rate in dogs (1 cM/Mb).
It has been suggested most chromosomal recombination
occurs in “hotspots” in the human genome and 50% of all
recombination occurs in less than 10% of the sequence
[15]. In addition, recombination hotspots are relatively
rare within or close to genes [16]. Although the region of
linkage disequilibrium becomes smaller with increasing
numbers of meiotic events (generations) after the founder
mutation occurred, the timing of the first descriptions of
ocular melanosis in Cairn terriers and the increasing inci-
dence of glaucoma in the breed [17], suggests that the mu-
tant allele became relatively common in the breed within
recent time (probably less than 10 generations ago [2] and
unpublished results). Thus, by using two markers, the
average recombination rate becomes a conservative esti-
mate, because of the small probability of the occurrence of
two hotspots within or near a gene that would lead to a
false exclusion.
Although it has been commented in several publica-
tions that some canine MS have observable mutations,
to our knowledge no actual tabulation of mutation rate
data has been published [18,19]. However, mutation rate
data are available for humans, with the highest rates
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We have used this highest human mutation rate as our
estimation of the rate of mutation at our MS. Although
it is possible that canine MS mutation rates could be
greater than this estimate, rates in dogs as little as two-
fold higher would likely have been previously detected
and published. With the approach used here, two rare
events (recombinations and/or marker mutations) would
have to occur to falsely exclude the causative gene. We
also note for exclusion analysis, recombinations and mu-
tations at loci which do not contain the disease causing
mutation do not alter the conclusions inferred from the
analysis; the only concern is for violations of the under-
lying assumptions at the causal locus, leading to a false
exclusion. With this approach and a single, necessary
gene being responsible for the disease, most candidate
genes can be screened in a relatively rapid and cost-
effective manner. In this particular case, it is highly un-
likely that the causal gene is among these 11 candidates.
Conclusions
This study provides strong evidence to exclude 11 po-
tential candidate genes from association with the Cairn
terrier OM locus. Further studies are required to identify
the gene mutation that is causal for this condition.
Methods
Animals
DNA was extracted by standard techniques from blood
samples from privately owned pet Cairn terriers that had
been diagnosed with OM by a veterinary ophthalmolo-
gist. The clinical information provided was reviewed by
SPJ or JTB. All procedures were in compliance with the
ARVO statement for the Use of Animals in Ophthalmic
and Vision Research and covered by Michigan State
University IACUC AUFs 05-08-076-00 or 05-11-106-00.
Development of polymorphic markers for candidate
genes
Candidate genes were selected because they either had a
known involvement in ocular pigmentary disturbances
in other species or a role in melanocytes and melano-
some development.
Two polymorphic markers were developed for each
gene (Table 1). Microsatellites (MS) were identified from
the USCS Genome Browser (http://genome.ucsc.edu/)
May 2005 build of the canine genome using the repeat
masker track. Single nucleotide polymorphism (SNP)
markers were selected from the list of canine SNPs
published by the Broad Institute of the Massachusetts
Institute of Technology (http://www.broadinstitute.org/
mammals/dog). With the exception of COMT MS1 and
GPNMB SNP2 all markers were within 600 kb from the
furthest end of the candidate for which they wereselected. Primers to amplify each marker by polymerase
chain reaction were designed using the Primer3 program
(http://frodo.wi.mit.edu/primer3/). A universal labeling
method was employed to fluorescently label the MS
PCR products [21]. The MS markers were sized on an
ABI PRISM 3130 genetic analyzer (Additional file 1:
Table S1). Restriction enzyme digest assays were
designed to allow genotyping of several of the SNPs (re-
striction enzymes shown in Table 1) and the other SNPs
genotyped by direct sequencing of the PCR products
(Additional file 1:Table S2).Calculation of probability of falsely excluding a genetic locus
Markers close to the causal gene mutation are likely to
be identical by descent in all affected alleles unless a re-
combination event between marker and mutation oc-
curred or the marker mutated. Either event could lead
to falsely excluding the candidate locus. Therefore, the
probability of a false exclusion of the causal gene due to
such inconsistencies was calculated (see Additional file 2
for an example of calculations). We first counted the
number of necessary recombination/mutation events to
obtain the genotype that would result in a false exclusion
of the true culprit gene. Then the greater of the two
probabilities of a recombination and a marker mutation
was used for subsequent calculations. In all cases, if a
marker was a SNP or an insertion/deletion the probabil-
ity of a recombination was used (i.e., a recurrent SNP
and insertion/deletion mutation is assumed to be always
rarer than the probability of a recombination event for
the data reported here). The probability of a recombi-
nation event was assumed to be proportional to the dis-
tance of the marker to the end of the most distant exon.
The recombination rate per unit of DNA is equivalent to
1 cM per Mb in the dog, based upon the estimates that
the autosomal sex-averaged linkage map is 26.5 Morgans
[22], and the physical map is 2631 Mb [23]. For all MS,
the probability of a marker mutation was assumed to be
0.01, based upon the mutation rate for a canine MS set
at the highest mutation rate seen among human MS
[20]. The probabilities for each recombination or marker
mutation event were then multiplied for both markers
if they flanked the gene on opposite sides, or for the
number of steps for a single marker if it was contained
within the gene (note that for markers that do not flank
both sides of a gene, it is possible for a single recom-
bination to produce non-shared alleles for both markers,
although the much tighter linkage for markers contained
within a gene can often make up for this disadvantage).
The probability was then adjusted for the estimated
number of generations (independent chances for a re-
combination/mutation) since the foundation event; 1 –
(1 – p)n, where n equals the estimated number of
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generations – based on first descriptions of OM).
Additional files
Additional file 1: Table S1. Genotyping results for microsatellites on
the ABI 3130 genetic analyzer. Dogs with one recombination or mutation
event are boxed. Light gray boxes indicate a second recombination or
mutation event. Dark gray boxes indicate a third recombination or
mutation event. Table S2. Biallelic genotyping results. Biallelic
genotyping results with SNP information, SNP # correlates with Table 1,
SNP position.
Additional file 2: Supplementary Methods. Example of p value
calculations using microsatellite markers.
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